Nanoantibiotics Inc Stock Other OTC
Equities
US63009U1025
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.69M 37.84M |
---|---|---|---|---|---|
Net income 2024 * | -49M -66.95M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.45
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.02% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |